← Leaderboards
James K. Wang
Dermalytica, Inc.
$713,590
Attributed
$713,590
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $258.6K · FY2015–20$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$713,590 · 3
By mechanism
R43$713,590 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Small Business Innovation Research Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Praduman Jain · Vignet, Inc.$106,968,877
- Stephen Lev Hoffman · Sanaria, Inc.$37,771,680
- Eric Baer · Case Western Reserve University$37,136,000
- John B Buse · University Of North Carolina Chapel Hill$23,865,764
- Gary Fanger · Rise Therapeutics, Llc$23,463,293
Research focus
Small Business Innovation Research GrantBacteriaPathogenSuccessBacteriophagesAcneCellsMedicalSkinAcutePropionibacterium AcnesAntibiotic ResistanceAntimicrobialIncidenceAge-YearsAffectAnti-Inflammatory AgentsAnti-InflammatoryFutureHost ResistanceBudgetsAntibioticsDermatologyAdverse Effects
Grant awards (3)
Lysterases as first-in-class prophylactic topical antimicrobials to prevent postsurgical shoulder infections$258,631
R43 · FY2020 · AI · contact PI
Targeted Antimicrobial Treatment of Acne Vulgaris with a novel class of Enzybiotics from Mycobacteriophage lysterases$229,997
R43 · FY2016 · AR · contact PI
Targeted Antimicrobial Treatment of Acne Vulgaris by Engineered High Molecular Weight Contractile Nanotubes$224,962
R43 · FY2015 · AR · contact PI